Brentuximab Vedotin for Systemic Sclerosis
Clinical trial NCT03222492 · COMPLETED
Trial details
- NCT number
- NCT03222492
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2023-04-10
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.